PPT-New Oral Anticoagulants: A Review

Babak Moini MD Veterans Affairs Hospital Noon Lecture S eries Acknowledgment Some of the slides were borrowed from Amanda Miller PharD Case1 68 male with hx of DM CHF and prior ischemic CVA admitted for new . Gonsalves MD Rajiv K Pruthi MBBS and Mrinal M Patnaik MBBS Abstract Vitamin K antagonists were the only class of oral anticoagulants available to clinicians for decades However with the US Food and Drug Administration approval of new oral anticoagul Tran J Joseph L Young S McRae J Curnow H Nandurkar P Wood and C McLintock Haemostasis Thrombosis Unit The Alfred Hospital Haematology Department Melbourne University Melbourne Victoria Haematology Department St Vincents Hospital Haemophilia Treatmen Fawaz Altuwaijri. ACEM trainee. Introduction. Characteristics . of novel . anticoagulants. Laboratory Testing. Reversal in the bleeding patient. Introduction. Prevalence . atrial fibrillation. . 3.03 million in 2005. UW-Madison Oral History Project. IWU Research . Seminar. 7 October 2015. Jan . Vansina. in . Living with Africa. [After describing the scene of an interview with one of his . Bushong. informants—. Adriana Clark, DDS. 1. Agenda. Introduction. Oral Cancer Facts. Oral Cancer Screening. Mucosa lesion assessment.. - Patient History. - Visual Screening Examination. . Extraoral. and Intraoral (Inspection-Palpation). Dr Than . Kyaw. 27 February 2012. COAGULATION. Complex process of blood clotting. Important part of . hemostasis. Cessation of blood loss from damaged vessel(s). Disorders of coagulation can lead to an increased risk of bleeding (hemorrhage) or clotting (thrombosis). . INTRODUCTION. Cancer is defined as the uncontrollable growth of cells that invade and cause damage to surrounding tissue. Oral cancer appears as a growth or sore in the mouth that does not go away. Oral cancer, which includes cancers of the lips, tongue, cheeks, floor of the mouth, hard and soft palate, sinuses, and pharynx (throat), can be life threatening if not diagnosed and treated early.. This presentation is based on the . December 2013. AHRQ WebM&M Spotlight Case. See the full article at . http://webmm.ahrq.gov. . CME credit is available. Commentary by: . Margaret . C. Fang. , MD, MPH, University of California, San Francisco. secretory. products into the oral cavity, the salivary glands. In the lab you will also have the opportunity the examine one other specialized epithelial area, the lip. The . oesophagus. is the first part of the alimentary canal. Its . , RN. Evy Warmbier, MSN, RN, CNE. Objectives. To Identify the Basic Hematological Components. To Understand the Clotting Cascade. To Relate the Fibrinolytic Systems Regarding Medication Administration. E388 12:E388-90. Dentigerous cyst associated with three teeth Med Oral Patol Oral Cir Bucal 2007; 12:E388-90. Dentigerous cyst associated with Antibiotic use in dental practice Oral Patol Oral Cir Bucal 200 Antibiotic use in dental practice Med Oral Patol Oral Cir Bucal 200 Valencia Correspondence: Dr. Rafael Department of Pediatric Dentistry, University of Texas, Health Science Center, San Antonio.Department of Orofacial Sciences, University of California at San Francisco.Disclosures: FIGURE 1. Squamous Presentation by: Amanda Spirit-Jones, Clare Thomson, Eleni Haramis, . Kylie Ryan and Laura Mobbs. Who are we?. Name. Setting. Role. Amanda Spirit-Jones. Disability - NGO. Leader and appraiser. Emma Minchin.